scholarly article | Q13442814 |
P356 | DOI | 10.1034/J.1600-051X.2000.027007466.X |
P698 | PubMed publication ID | 10914886 |
P2093 | author name string | Brecx M | |
Donos N | |||
Karring T | |||
Reich E | |||
Sculean A | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 466-472 | |
P577 | publication date | 2000-07-01 | |
P1433 | published in | Journal of Clinical Periodontology | Q15638559 |
P1476 | title | Treatment of intrabony defects with guided tissue regeneration and enamel-matrix-proteins. An experimental study in monkeys | |
P478 | volume | 27 |
Q80389017 | A study of enamel matrix proteins on differentiation of porcine bone marrow stromal cells into cementoblasts |
Q46292174 | Adsorption of enamel matrix proteins to a bovine-derived bone grafting material and its regulation of cell adhesion, proliferation, and differentiation |
Q33227207 | Anti-infective therapy with an Er:YAG laser: influence on peri-implant healing |
Q51301267 | Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra-osseous defects: a report of 13 consecutively treated patients. |
Q39601360 | Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects |
Q38151146 | Comparison of treatment effects of guided tissue regeneration on infrabony lesions between animal and human studies: a systematic review and meta-analysis |
Q53243194 | Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1-year retrospective study. |
Q59193449 | Effect of Autogenous Cortical Bone Particulate in Conjunction With Enamel Matrix Derivative in the Treatment of Periodontal Intraosseous Defects |
Q47431617 | Effect of GBR in combination with deproteinized bovine bone mineral and/or enamel matrix proteins on the healing of critical-size defects |
Q31027713 | Effect of an enamel matrix protein derivative (Emdogain) on ex vivo dental plaque vitality |
Q46825562 | Effect of an oily calcium hydroxide suspension (Osteoinductal) on healing of intrabony periodontal defects. A pilot study in dogs. |
Q44599420 | Effects of Enamel Matrix Derivative on Porphyromonas gingivalis |
Q45283917 | Effects of enamel matrix proteins on tissue formation along the roots of human teeth |
Q57727524 | Enamel Matrix Protein Adsorption to Root Surfaces in the Presence or Absence of Human Blood |
Q83351962 | Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects |
Q51576614 | Enamel matrix derivative and guided tissue regeneration in the treatment of dehiscence-type defects: a histomorphometric study in dogs. |
Q44402881 | Enamel matrix derivative and titanium implants |
Q51133354 | Enamel matrix derivative versus guided tissue regeneration in the presence of nicotine: a histomorphometric study in dogs. |
Q38106956 | Enamel matrix protein derivatives: role in periodontal regeneration |
Q37765811 | Experimental animal models in periodontology: a review |
Q42659738 | Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series |
Q42629143 | Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration |
Q84865803 | Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate |
Q35670360 | Growth and amelogenin-like factors in periodontal wound healing. A systematic review. |
Q43947029 | Guided tissue regeneration may modulate gene expression in periodontal intrabony defects: a human study |
Q53978886 | Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study. |
Q73287996 | Healing of intrabony defects following treatment with a bovine-derived xenograft and collagen membrane. A controlled clinical study |
Q51301702 | Healing of intrabony defects following treatment with an oily calcium hydroxide suspension (Osteoinductal). A controlled clinical study. |
Q75317754 | Healing of periodontal defects treated with enamel matrix proteins and root surface conditioning--an experimental study in dogs |
Q47719936 | Healing of two-wall intra-bony defects treated with a novel EMD-liquid-A pre-clinical study in monkeys |
Q41833209 | Histological characteristics of newly formed cementum in surgically created one-wall intrabony defects in a canine model. |
Q42812144 | Immunohistochemical analysis of periodontal reattachment on denuded root dentin after periodontal surgery |
Q44341272 | Immunohistochemical investigation on the pattern of vimentin expression in regenerated and intact monkey and human periodontal ligament |
Q46923696 | In vitro biologic response of human bone marrow stromal cells to enamel matrix derivative. |
Q35866617 | Pre-clinical models for oral and periodontal reconstructive therapies. |
Q36474306 | Regeneration of periodontal tissues: cementogenesis revisited |
Q64114009 | Regeneration of the Periodontal Apparatus in Aggressive Periodontitis Patients |
Q52038794 | Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects. |
Q51688518 | Susceptibility of GTR-regenerated periodontal attachment to ligature-induced periodontitis. |
Q46556592 | The combined use of enamel matrix proteins and a tetracycline-coated expanded polytetrafluoroethylene barrier membrane in the treatment of intra-osseous defects |
Q44558095 | The effect of enamel matrix proteins on periodontal regeneration as determined by histological analyses |
Q44421357 | The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteins |
Q40647121 | The effects of enamel matrix derivative (EMD) on osteoblastic cells in culture and bone regeneration in a rat skull defect |
Q51148623 | The structure of periodontal tissues formed following guided tissue regeneration therapy of intra-bony defects in the monkey. |
Q35969359 | The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis |
Q85590938 | Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft |
Q35770372 | Tissue engineering: A new vista in periodontal regeneration |
Q49192216 | Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model |
Q52062830 | Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. |
Q47306077 | Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial. |
Q35024507 | Treatment of intrabony periodontal defects with enamel matrix derivative: a literature review |
Q84193026 | Treatment of periodontal defects in dogs using an injectable composite hydrogel/biphasic calcium phosphate |
Q38778569 | Twenty years of enamel matrix derivative: the past, the present and the future |
Q36011890 | Which reconstructive procedures are effective for treating the periodontal intraosseous defect? |
Q85240998 | Wound healing following regenerative procedures in furcation degree III defects: histomorphometric outcomes |
Q33198843 | Wound healing of degree III furcation involvements following guided tissue regeneration and/or Emdogain. A histologic study |